Conference to focus on the impact of healthcare proposals on diagnostic testing

Enzo Biochem, Inc. (NYSE:ENZ) announced today that Kevin Krenitsky, MD, President of Enzo Clinical Labs, will present at the 27^th Annual Lab Institute ’09, sponsored by Washington G2 Reports, on September 23, 2009 in Arlington, Virginia.

Dr. Krenitsky will present at a panel discussion entitled “Going Inside the Boardroom: What’s the Bottom Line for Labs During a Time of Economic, Policy and Market Flux?”

Among the meeting’s keynote speakers will be the Hon. Newt Gingrich, former Speaker of the U.S. House of Representatives, and Rep. Pete Stark (D-CA), Chairman, House Ways and Means Health Subcommittee.

“The focus of this key conference, which comes at a pivotal time in the debate over health care reform, will be on the impact various proposals will have on diagnostic testing, which, given all the advances being made in diagnosing diseases and how treatments are gauged, will figure importantly in the way medicine is practiced and patients treated in the future,” said Dr. Krenitsky. “It is a welcome opportunity that a leading independent laboratory such as Enzo Clinical Labs has been invited to be part of this dialogue.”

www.enzo.com